Early warning and accurate screening for the high-risk population of hepatocellular carcinoma / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 499-504, 2022.
Article
в Zh
| WPRIM
| ID: wpr-922941
Ответственная библиотека:
WPRO
ABSTRACT
It is an effective way to improve the early diagnosis rate of hepatocellular carcinoma (HCC) in China by conducting standardized screening among the population with chronic liver diseases, achieving accurate stratification and standardized management of the population at a risk of HCC, and realizing the early warning for HCC through effective technical means. In clinical practice, the risk scoring models for liver cancer including aMAP can be used for preliminary risk screening of the population with chronic liver diseases to identify the population with a moderate or high risk of liver cancer. Novel serum biomarkers can be used to further screen out the population with an extremely high risk of liver cancer, and then imaging technology can be used for early diagnosis. Constant exploration and improvement of the "pyramid" screening and management mode through stratified enrichment may help to achieve the goal of improving early diagnosis rate of HCC and reducing HCC-related mortality.
Полный текст:
1
База данных:
WPRIM
Тип исследования:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Screening_studies
Язык:
Zh
Журнал:
Journal of Clinical Hepatology
Год:
2022
Тип:
Article